Last updated: 2026-09-21 23:26:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Artivion, Inc. (AORT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $23.63, with a market capitalization of $1.14B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $19.16 to $48.25. This page covers its latest market performance, valuation, price trends and company information.
$1.14B | |
$23.27 | |
$48.25 | |
$9.64 | |
$23.35 | |
416.68K | |
718.10K | |
-- | |
$48.25 | |
$19.16 | |
-- | |
-- |
Artivion, Inc. (AORT) is trading at $23.64 in after-hours trading as of 2026-09-21 23:00:00, up 1.22% ($0.29) from the regular-session close of $23.35.
After-hours trading shows how investors are pricing AORT after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Artivion, Inc. (AORT) moved from $24.65 to $23.63, representing a decline of 4.13% ($1.02).
The stock traded between $20.93 and $25.75 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 851.58 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 15.4%
AORT is currently trading at $23.63, placing it 15.4% of the way from its 52-week low of $19.16 to its 52-week high of $48.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 1800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Artivion, Inc. (AORT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.